Allogene Therapeutics Inc (ALLO)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.31B
EV to revenue ratio (TTM)
21.11
EV to ebitda
-1.04
Financial Performance
Revenue (TTM)
$0.00B
Gross profit (TTM)
-$0.13B
EBITDA
-$0.18B
Profitability
Operating margin (TTM)
-4,173.00%
Profit margin
<0.01%
Return on assets (TTM)
-25.50%
Return on equity (TTM)
-49.30%
Per Share Metrics
Revenue per share (TTM)
$0.02
EPS
-$0.59
Diluted EPS (TTM)
-$0.59
Book value
$1.13
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
n/a
Price to sales ratio (TTM)
67.21
Price to book ratio (TTM)
0.82
Growth
Quarterly earnings growth (YoY)
-100.00%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
3
Buy
8
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.78